These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1715401)

  • 21. Physicochemical characterization of spray-dried phenylbutazone polymorphs.
    Matsuda Y; Kawaguchi S; Kobayashi H; Nishijo J
    J Pharm Sci; 1984 Feb; 73(2):173-9. PubMed ID: 6707878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RH-Temperature Stability Diagram of the Dihydrate, β-Anhydrate, and α-Anhydrate Forms of Crystalline Trehalose.
    Allan M; Chamberlain MC; Mauer LJ
    J Food Sci; 2019 Jun; 84(6):1465-1476. PubMed ID: 31042816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and Stability of Amorphous Tadalafil and Four Crystalline Polymorphs.
    Wei Y; Ling Y; Su M; Qin L; Zhang J; Gao Y; Qian S
    Chem Pharm Bull (Tokyo); 2018; 66(12):1114-1121. PubMed ID: 30504628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neotame anhydrate polymorphs I: preparation and characterization.
    Doug Z; Padden BE; Salsbury JS; Munson EJ; Schroeder SA; Prakash I; Grant DJ
    Pharm Res; 2002 Mar; 19(3):330-6. PubMed ID: 11934241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-amorphous Formation Induced by Combination of Tranilast and Diphenhydramine Hydrochloride.
    Ueda H; Kadota K; Imono M; Ito T; Kunita A; Tozuka Y
    J Pharm Sci; 2017 Jan; 106(1):123-128. PubMed ID: 27539557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption improvement of tranilast by forming highly soluble nano-size composite structures associated with α-glucosyl rutin via spray drying.
    Sato H; Fujimori M; Suzuki H; Kadota K; Shirakawa Y; Onoue S; Tozuka Y
    Eur J Pharm Biopharm; 2015 May; 92():49-55. PubMed ID: 25725261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved processability of ethambutol hydrochloride by spherical agglomeration.
    Nitsure A; Patel D; Wairkar S
    Pharm Dev Technol; 2020 Mar; 25(3):376-384. PubMed ID: 31842656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-ray crystallographic characterization of nilvadipine monohydrate and its phase transition behavior.
    Hirayama F; Honjo M; Arima H; Okimoto K; Uekama K
    Eur J Pharm Sci; 2000 Jul; 11(1):81-8. PubMed ID: 10913756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-solvent polymorph screen of carbamazepine.
    Getsoian A; Lodaya RM; Blackburn AC
    Int J Pharm; 2008 Feb; 348(1-2):3-9. PubMed ID: 17945448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism of estramustine.
    Wadsten T; Lindberg NO
    J Pharm Sci; 1989 Jul; 78(7):563-6. PubMed ID: 2778656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
    Pandey S; Patil AT
    Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-state properties and relationship between anhydrate and monohydrate of baclofen.
    Mirza S; Miroshnyk I; Rantanen J; Aaltonen J; Harjula P; Kiljunen E; Heinämäki J; Yliruusi J
    J Pharm Sci; 2007 Sep; 96(9):2399-408. PubMed ID: 17549770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
    Maghsoodi M
    Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical and structural comparison of oxyphenbutazone monohydrate and anhydrate.
    Stoltz M; Caira MR; Lotter AP; van der Watt JG
    J Pharm Sci; 1989 Sep; 78(9):758-63. PubMed ID: 2585271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of ibuprofen crystallized under various conditions: a comparative study.
    Rasenack N; Müller BW
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1077-89. PubMed ID: 12455467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of moricizine hydrochloride polymorphs.
    Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of environmental humidity on the transformation pathway of nitrofurantoin modifications during grinding and the physicochemical properties of ground products.
    Otsuka M; Matsuda Y
    J Pharm Pharmacol; 1993 May; 45(5):406-13. PubMed ID: 8099957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Particle design of tolbutamide in the presence of soluble polymer or surfactant by the spherical crystallization technique: improvement of dissolution rate.
    Sano A; Kuriki T; Handa T; Takeuchi H; Kawashima Y
    J Pharm Sci; 1987 Jun; 76(6):471-4. PubMed ID: 3625493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.
    Kimura K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Apr; 88(4):385-91. PubMed ID: 10187747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.